BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22879203)

  • 21. The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial.
    Chadid S; Barber JR; Nelson WG; Gurel B; Lucia MS; Thompson IM; Goodman PJ; Stanczyk FZ; Parnes HL; Lippman SM; De Marzo AM; Platz EA
    Prostate; 2020 Aug; 80(11):895-905. PubMed ID: 32506665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
    Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
    J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo uptake and metabolism of 3-h-5alpha-androstane-3alpha,17beta-diol and of 3-h-5alpha-androstane-3beta,17beta-diol by human prostatic hypertrophy.
    Horst HJ; Dennis M; Kaufmann J; Voigt KD
    Acta Endocrinol (Copenh); 1975 Jun; 79(2):394-402. PubMed ID: 49141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation of 5α-dihydrotestosterone from 5α-androstane-3α,17β-diol in prostate cancer LAPC-4 cells - Identifying inhibitors of non-classical pathways producing the most potent androgen.
    Boutin S; Roy J; Maltais R; Poirier D
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126783. PubMed ID: 31753699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.
    Schenk JM; Till CA; Tangen CM; Goodman PJ; Song X; Torkko KC; Kristal AR; Peters U; Neuhouser ML
    Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1484-93. PubMed ID: 25085836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen metabolism in men receiving finasteride before prostatectomy.
    Norman RW; Coakes KE; Wright AS; Rittmaster RS
    J Urol; 1993 Nov; 150(5 Pt 2):1736-9. PubMed ID: 7692110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.
    Lévesque É; Laverdière I; Lacombe L; Caron P; Rouleau M; Turcotte V; Têtu B; Fradet Y; Guillemette C
    Clin Cancer Res; 2014 Feb; 20(3):576-84. PubMed ID: 24277450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
    Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
    Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific antigen, sex steroid hormones, and the insulin-like growth factor axis in U.S.-born, Jamaican, and Haitian black men: a pilot study.
    Chen AC; MacChia RJ; Conway F; Magai C; Desai M; Neugut AI
    Urology; 2004 Sep; 64(3):522-7. PubMed ID: 15351583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation.
    Nunlist EH; Dozmorov I; Tang Y; Cowan R; Centola M; Lin HK
    J Steroid Biochem Mol Biol; 2004 Jul; 91(3):157-70. PubMed ID: 15276623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    Traish AM; Morgentaler A
    J Steroid Biochem Mol Biol; 2013 Nov; 138():462. PubMed ID: 23851167
    [No Abstract]   [Full Text] [Related]  

  • 34. Distinct testicular 17-ketosteroid reductases, one in interstitial tissue and one in seminiferous tubules. Differential modulation by testosterone and metabolites of testosterone.
    Murono EP; Payne AH
    Biochim Biophys Acta; 1976 Oct; 450(1):89-100. PubMed ID: 10012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease.
    Hoque A; Yao S; Till C; Kristal AR; Goodman PJ; Hsing AW; Tangen CM; Platz EA; Stanczyk FZ; Reichardt JK; vanBokhoven A; Neuhouser ML; Santella RM; Figg WD; Price DK; Parnes HL; Lippman SM; Ambrosone CB; Thompson IM
    Urology; 2015 Mar; 85(3):616-20. PubMed ID: 25733274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer.
    Black A; Pinsky PF; Grubb RL; Falk RT; Hsing AW; Chu L; Meyer T; Veenstra TD; Xu X; Yu K; Ziegler RG; Brinton LA; Hoover RN; Cook MB
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2374-82. PubMed ID: 25178985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization against 5alpha-androstane-3alpha,17beta-diol affects ovarian folliculogenesis in Merino ewes.
    Tetsuka M; Nancarrow CD
    Theriogenology; 2003 Jul; 60(2):307-17. PubMed ID: 12749944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.
    Zhou CK; Stanczyk FZ; Hafi M; Veneroso CC; Lynch B; Falk RT; Niwa S; Emanuel E; Gao YT; Hemstreet GP; Zolfghari L; Carroll PR; Manyak MJ; Sesterhenn IA; Levine PH; Hsing AW; Cook MB
    Prostate; 2017 Dec; 77(16):1573-1582. PubMed ID: 28971497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding and metabolism of 5alpha-androstane-3alpha, 17 beta-diol and of 5alpha-androstane-3beta, 17 beta-diol in the prostate, seminal vesicles and plasma of male rats: studies in vivo and in vitro.
    Krieg M; Horst HJ; Sterba ML
    J Endocrinol; 1975 Mar; 64(3):529-38. PubMed ID: 1133541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous determination of testosterone, 5alpha-androstan-17beta-ol-3-one, 5alpha-androstane-3alpha,17beta-diol and 5alpha-androstane-3beta,17beta-diol in plasma of adult male rabbits by radioimmunoassay(1).
    Schanbacher BD; Ewing LL
    Endocrinology; 1975 Oct; 97(4):787-92. PubMed ID: 1193006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.